Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neridronic acid in complex regional pain syndrome type I
2014-001915-37Phase 2Completed
- Sponsor
- Grünenthal GmbH
- Start
- Mar 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Complex Regional Pain Syndrome Type 1 (CRPS-1) comparing Neridronic acid with Placebo (2 arms). Primary endpoint: Change in Pain Intensity Score from baseline to Week 12. Started Mar 2015; status: completed.
02
Drugs
neridronic acid
03
Conditions
Complex Regional Pain Syndrome Type 1 (CRPS-1)
Beyond the preview
Go deeper on 2014-001915-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-001915-37.